USVP, a top-tier early-stage venture capital firm achieved to close its USVP XI, a $300M fund. The new fund continues USVP’s leading franchises in cybersecurity, enterprise software, consumer mobile, e-commerce and healthcare. The VC has led early-stage investments in 86 companies that have completed initial public offerings. At the same time, 24 of the companies have had profitable exits and 6 of have attained greater than billion dollar valuations through an IPO or M&A.
USVP’s strategy is to be the lead Series A investor in companies based in the U.S. or Israel, in four core sectors: cybersecurity, enterprise software, consumer mobile and e-commerce, and healthcare. “In closing USVP XI, we are building on an extensive track record of successful early-stage investing in transformative businesses with massive market potential. Box, Imperva, InsideSales, Intersect ENT, and Trunk Club all have become globally-recognized leaders in their markets. Our results are not just on paper; in fact, USVP has distributed over one billion dollars to its limited partners during this same five year period. Our team has achieved these results by recognizing promising entrepreneurs early in their careers and investing in companies early in their development. We have been fortunate that many have gone on to become the undisputed leaders in their industries and markets” said Steve Krausz, General Partner.
